Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting

Document Details

Document Type
Pub Defense Publication
Publication Date
Dec 01, 2021
Source ID
10.1016/j.biomaterials.2021.121184

Entities

People

  • Alex Schudel
  • Alexander J. Heiler
  • David M. Francis
  • Lauren F Sestito
  • Margaret P Manspeaker
  • Paul A. Archer
  • Susan N Thomas

Organizations

  • American Heart Association
  • National Institutes of Health
  • National Science Foundation
  • Susan G. Komen for the Cure
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech